FR940617-1-00095 FR940617-1-00012 (3) Other allowable indications for products labeled as either antiseptic or health-care handwash. The labeling of the product may also contain the following phrase: ``Recommended for repeated use.'' (c) Directions. The labeling of the product contains the following statements, under the heading ``Directions,'' that reflect the conditions used when the product was tested according to §333.470(b)(2): (1) For products to be used with water. ``Wet hands and forearms. Apply 5 milliliters (teaspoonful) or palmful to hands and forearms. Scrub thoroughly for'' (insert wash duration used when tested according to §333.470(b)(2)). (Insert any applicable statements about also using a device, such as a scrub brush.) ``Rinse and repeat.'' (2) For products to be used without water. ``Place a `palmful' (5 grams) of product in one hand. Spread on both hands and rub into the skin until dry (approximately 1 to 2 minutes). Place a smaller amount (2.5 grams) into one hand, spread over both hands to wrist, and rub into the skin until dry (approximately 30 seconds)'' or ``Wet hands thoroughly with product and allow to dry without wiping.'' §333.460 Labeling of patient preoperative skin preparation drug products. (a) Statement of identity. The labeling of the product contains the established name of the drug, if any, and identifies the product as an ``antiseptic,'' as stated under §333.450(a), and/or ``patient preoperative skin preparation.'' (b) Indications. The labeling of the product states, under the heading ``Indications,'' any of the phrases listed in paragraph (b) of this section. Other truthful and nonmisleading statements, describing only the indications for use that have been established and listed in this paragraph, may also be used, as provided in §330.1(c)(2) of this chapter, subject to the provisions of section 502 of the Federal Food, Drug, and Cosmetic Act (the act) relating to misbranding and the prohibition in section 301(d) of the act against the introduction or delivery for introduction into interstate commerce of unapproved new drugs in violation of section 505(a) of the act. (1) For products containing ingredients identified in §333.412 (a), (b), (c), and (e). (i) ``For preparation of the skin prior to surgery.'' (ii) ``Helps reduce bacteria that potentially can cause skin infection.'' (2) For products containing alcohol identified in §333.412(a). In addition to the indications listed in §333.460(1), the labeling may also include the statement ``For preparation of the skin prior to an injection.'' (3) For products containing isopropyl alcohol identified in §333.412(d). ``For preparation of the skin prior to an injection.''
